Guidelines for the Selection of Lung Transplantation Candidates;Normativa para la selección de pacientes candidatos a trasplante pulmonar

Archivos de Bronconeumologia

Volumn 47, Issue 6, 2011, Pages 303-309

  Román, Antonio ^a,b   Ussetti, Pietat ^c   Solé, Amparo ^d   Zurbano, Felipe ^e   Borro, José M ^f   Vaquero, José M ^g   de Pablo, Alicia ^h   Morales, Pilar ^f   Blanco, Marina ^d   Bravo, Carlos ^a,b   Cifrian, José ^e   de la Torre, Mercedes ^f   Gámez, Pablo ^c   Laporta, Rosalía ^c   Monforte, Víctor ^a,b   Mons, Roberto ^e   Salvatierra, Ángel ^g   Santos, Francisco ^g   Solé, Joan ^a   Varela, Andrés ^c  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^d HOSPITAL UNIVERSITARIO LA FE   (Spain)

^e HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^f HOSPITAL JUAN CANALEJO   (Spain)

^g HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^h HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

COPD; Lung transplantation; Pre operative study; Pulmonary fibrosis

Indexed keywords

ARTICLE; LUNG TRANSPLANTATION; PATIENT IDENTIFICATION; PATIENT INFORMATION; PATIENT SELECTION; PRACTICE GUIDELINE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONSENSUS; CYSTIC FIBROSIS; EVIDENCE BASED PRACTICE; HEALTH PRACTITIONER; HEALTH PROGRAM; HOSPITAL ADMISSION; HUMAN; INTERSTITIAL LUNG DISEASE; JOB EXPERIENCE; MEDICAL DECISION MAKING; PATIENT CARE; PATIENT CODING; PATIENT REFERRAL; PUBLICATION; PULMONARY HYPERTENSION; PULMONOLOGIST; SPAIN; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

EID: 85037813480     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/j.arbr.2011.03.002     Document Type: Article

References (55)

1. Christie J.D., Edwards L.B., Aurora P., Dobbels F., Kirk R., Rahmel A.O., et al. The registry of the international society for heart and lung transplantation: twenty-sixth official adult lung and heart-lung transplantation Report-2009. J Heart Lung Transplant 2009, 28:1031-1049.
2. Orens J.B., Estenne M., Arcasoy S., Conte J.V., Corris P., Egan J.J., et al. International guidelines for the selection of lung transplant candidates: 2006 update-a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006, 25:745-755.
3. Charman S.C., Sharples L.D., McNeil K.D., Wallwork J. Assessment of survival benefit after lung transplantation by patient diagnosis. J Heart Lung Transplant 2002, 21:226-232.
4. Hosenpud J.D., Bennett L.E., Keck B.M., Edwards E.B., Novick R.J. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet 1998, 351:24-27.
5. Gerbase M.W., Spiliopoulos A., Rochat T., Archinard M., Nicod L.P. Health-related quality of life following single or bilateral lung transplantation: a 7-year comparison to functional outcome. Chest 2005, 128:1371-1378.
6. Geertsma A., ten Vergert E.M., Bonsel G.J., de Boer W.J., van der B.W. Does lung transplantation prolong life? A comparison of survival with and without transplantation. J Heart Lung Transplant 1998, 17:511-516.
7. Connors A.F., Dawson N.V., Thomas C., Harrell F.E., Desbiens N., Fulkerson W.J., et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med 1996, 154:959-967.
8. Fishman A., Martinez F., Naunheim K., Piantadosi S., Wise R., Ries A., et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003, 348:2059-2073.
9. Oga T., Nishimura K., Tsukino M., Sato S., Hajiro T. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med 2003, 167:544-549.
10. Celli B.R., Cote C.G., Marin J.M., Casanova C., Montes D.O., Mendez R.A., et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004, 350:1005-1012.
11. Ussetti P., Laporta R. Predicting outcomes in chronic obstructive pulmonary disease. N Engl J Med 2004, 350:2308-2310.
12. Cobos M.J., Navas B., Vaquero J.M., Santos F. Índice de BODE en pacientes trasplantados de pulmón por EPOC. Neumosur 2008, 20:199-203.
13. Egan T.M., Bennett L.E., Garrity E.R., Grover F.L., Ring W.S., Robbins R.C., et al. Predictors of death on the UNOS lung transplant waiting list: results of a multivariate analysis. J Heart Lung Transplant 2001, 20:242.
14. Flaherty K.R., Toews G.B., Travis W.D., Colby T.V., Kazerooni E.A., Gross B.H., et al. Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J 2002, 19:275-283.
15. Flaherty K.R., Travis W.D., Colby T.V., Toews G.B., Kazerooni E.A., Gross B.H., et al. Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med 2001, 164:1722-1727.
16. Katzenstein A.L., Fiorelli R.F. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 1994, 18:136-147.
17. Rosas V., Conte J.V., Yang S.C., Gaine S.P., Borja M., Wigley F.M., et al. Lung transplantation and systemic sclerosis. Ann Transplant 2000, 5:38-43.
18. Alhamad E.H., Lynch J.P., Martinez F.J. Pulmonary function tests in interstitial lung disease: what role do they have?. Clin Chest Med 2001, 22:715-750.
19. King T.E., Safrin S., Starko K.M., Brown K.K., Noble P.W., Raghu G., et al. Analyses of efficacy end points in a controlled trial of interferon-gamma1b for idiopathic pulmonary fibrosis. Chest 2005, 127:171-177.
20. Collard H.R., King T.E., Bartelson B.B., Vourlekis J.S., Schwarz M.I., Brown K.K. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003, 168:538-542.
21. Martínez F.J., Safrin S., Weycker D., Starko K.M., Bradford W.Z., King T.E., et al. The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med 2005, 142:963-967.
22. Latsi P.I., du Bois R.M., Nicholson A.G., Colby T.V., Bisirtzoglou D., Nikolakopoulou A., et al. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am J Respir Crit Care Med 2003, 168:531-537.
23. Lama V.N., Flaherty K.R., Toews G.B., Colby T.V., Travis W.D., Long Q., et al. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003, 168:1084-1090.
24. Mogulkoc N., Brutsche M.H., Bishop P.W., Greaves S.M., Horrocks A.W., Egan J.J. Pulmonary function in idiopathic pulmonary fibrosis and referral for lung transplantation. Am J Respir Crit Care Med 2001, 164:103-108.
25. Douglas W.W., Ryu J.H., Schroeder D.R. Idiopathic pulmonary fibrosis: Impact of oxygen and colchicine, prednisone, or no therapy on survival. Am J Respir Crit Care Med 2000, 161:1172-1178.
26. Raghu G., Depaso W.J., Cain K., Hammar S.P., Wetzel C.E., Dreis D.F., et al. Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial. Am Rev Respir Dis 1991, 144:291-296.
27. Raghu G., Brown K.K., Bradford W.Z., Starko K., Noble P.W., Schwartz D.A., et al. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med 2004, 350:125-133.
28. Raghu G., Johnson W.C., Lockhart D., Mageto Y. Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label Phase II study. Am J Respir Crit Care Med 1999, 159:1061-1069.
29. Raghu G., Brown K.K., Costabel U., Cottin V., du Bois R.M., Lasky J.A., et al. Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial. Am J Respir Crit Care Med 2008, 178:948-955.
30. King T.E., Behr J., Brown K.K., du Bois R.M., Lancaster L., de Andrade J.A., et al. BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2008, 177:75-81.
31. Egan T.M., Detterbeck F.C., Mill M.R., Bleiweis M.S., Aris R., Paradowski L., et al. Long term results of lung transplantation for cystic fibrosis. Eur J Cardiothorac Surg 2002, 22:602-609.
32. Liou T.G., Adler F.R., Huang D. Use of lung transplantation survival models to refine patient selection in cystic fibrosis. Am J Respir Crit Care Med 2005, 171:1053-1059.
33. Liou T.G., Adler F.R., Cahill B.C., FitzSimmons S.C., Huang D., Hibbs J.R., et al. Survival effect of lung transplantation among patients with cystic fibrosis. JAMA 2001, 286:2683-2689.
34. Liou T.G., Adler F.R., Cox D.R., Cahill B.C. Lung transplantation and survival in children with cystic fibrosis. N Engl J Med 2007, 357:2143-2152.
35. Morton J., Glanville A.R. Lung transplantation in patients with cystic fibrosis. Semin Respir Crit Care Med 2009, 30:559-568.
36. Hofer M., Benden C., Inci I., Schmid C., Irani S., Speich R., et al. True survival benefit of lung transplantation for cystic fibrosis patients: the Zurich experience. J Heart Lung Transplant 2009, 28:334-339.
37. Weiss E.S., Allen J.G., Modi M.N., Merlo C.A., Conte J.V., Shah A.S. Lung transplantation in older patients with cystic fibrosis: analysis of UNOS data. J Heart Lung Transplant 2009, 28:135-140.
38. Corris P.A. Lung transplantation for cystic fibrosis. Curr Opin Organ Transplant 2008, 13:484-488.
39. Algar F.J., Cano J.R., Moreno P., Espinosa D., Cerezo F., Alvarez A., et al. Results of lung transplantation in patients with cystic fibrosis. Transplant Proc 2008, 40:3085-3087.
40. De Soyza A., Morris K., McDowell A., Doherty C., Archer L., Perry J., et al. Prevalence and clonality of Burkholderia cepacia complex genomovars in UK patients with cystic fibrosis referred for lung transplantation. Thorax 2004, 59:526-528.
41. Aris R.M., Gilligan P.H., Neuringer I.P., Gott K.K., Rea J., Yankaskas J.R. The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome. Am J Respir Crit Care Med 1997, 55:1699-1704.
42. Dobbin C., Maley M., Harkness J., Benn R., Malouf M., Glanville A., et al. The impact of pan-resistant bacterial pathogens on survival after lung transplantation in cystic fibrosis: results from a single large referral centre. J Hosp Infect 2004, 56:277-282.
43. Chaparro C., Maurer J., Gutierrez C., Krajden M., Chan C., Winton T., et al. Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation. Am J Respir Crit Care Med 2001, 163:43-48.
44. Aris R.M., Routh J.C., LiPuma J.J., Heath D.G., Gilligan P.H. Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type. Am J Respir Crit Care Med 2001, 164:2102-2106.
45. Flume P.A., Egan T.M., Westerman J.H., Paradowski L.J., Yankaskas J.R., Detterbeck F.C., et al. Lung transplantation for mechanically ventilated patients. J Heart Lung Transplant 1994, 13:15-21.
46. Bartz R.R., Love R.B., Leverson G.E., Will L.R., Welter D.L., Meyer K.C. Pre-transplant mechanical ventilation and outcome in patients with cystic fibrosis. J Heart Lung Transplant 2003, 22:433-438.
47. Mayer-Hamblett N., Rosenfeld M., Emerson J., Goss C.H., Aitken M.L. Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality. Am J Respir Crit Care Med 2002, 166:1550-1555.
48. Ellaffi M., Vinsonneau C., Coste J., Hubert D., Burgel P.R., Dhainaut J.F., et al. One-year outcome after severe pulmonary exacerbation in adults with cystic fibrosis. Am J Respir Crit Care Med 2005, 171:158-164.
49. Davis P.B. The gender gap in cystic fibrosis survival. J Gend Specif Med 1999, 2:47-51.
50. D'Alonzo G.E., Barst R.J., Ayres S.M., Bergofsky E.H., Brundage B.H., Detre K.M., et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991, 115:343-349.
51. Kamler M., Pizanis N., Aleksic I., Ragette R., Jakob H.G. Pulmonary hypertension and lung transplantation. Herz 2005, 30:281-285.
52. López-Meseguer M., Román A., Monforte V., Bravo C., Sole J., Morell F. Double-lung transplantation in 15 patients with pulmonary hypertension. Arch Bronconeumol 2009, 45:366-370.
53. Barberà J.A., Escribano P., Morales P., Gómez M.A., Oribe M., Martínez A., et al. [Standards of care in pulmonary hypertension. Consensus Statement of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) and the Spanish Society of Cardiology (SEC)]. Arch Bronconeumol 2008, 44:87-99.
54. Galie N., Hoeper M.M., Humbert M., Torbicki A., Vachiery J.L., Barbera J.A., et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. The task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Respir J 2009, 34:1219-1263.
55. Barst R.J., Gibbs J.S., Ghofrani H.A., Hoeper M.M., McLaughlin V.V., Rubin L.J., et al. Updated evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol 2009, 54:S78-S84.